Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

128 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cost-effectiveness analysis comparing ceftazidime/avibactam (CAZ-AVI) as empirical treatment comparing to ceftolozane/tazobactam and to meropenem for complicated intra-abdominal infection (cIAI).
Kongnakorn T, Eckmann C, Bassetti M, Tichy E, Di Virgilio R, Baillon-Plot N, Charbonneau C. Kongnakorn T, et al. Among authors: charbonneau c. Antimicrob Resist Infect Control. 2019 Dec 21;8:204. doi: 10.1186/s13756-019-0652-x. eCollection 2019. Antimicrob Resist Infect Control. 2019. PMID: 31890160 Free PMC article.
Cost-effectiveness Comparison of Ceftazidime/Avibactam Versus Meropenem in the Empirical Treatment of Hospital-acquired Pneumonia, Including Ventilator-associated Pneumonia, in Italy.
Tichy E, Torres A, Bassetti M, Kongnakorn T, Di Virgilio R, Irani P, Charbonneau C. Tichy E, et al. Among authors: charbonneau c. Clin Ther. 2020 May;42(5):802-817. doi: 10.1016/j.clinthera.2020.03.014. Epub 2020 Apr 27. Clin Ther. 2020. PMID: 32349879 Free article. Clinical Trial.
Comparison of vancomycin and linezolid in patients with peripheral vascular disease and/or diabetes in an observational European study of complicated skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus.
Eckmann C, Nathwani D, Lawson W, Corman S, Solem C, Stephens J, Macahilig C, Li J, Charbonneau C, Baillon-Plot N, Haider S. Eckmann C, et al. Among authors: charbonneau c. Clin Microbiol Infect. 2015 Sep;21 Suppl 2:S33-9. doi: 10.1016/j.cmi.2015.01.011. Epub 2015 Jul 18. Clin Microbiol Infect. 2015. PMID: 26198370 Free article.
Implementing criteria-based early switch/early discharge programmes: a European perspective.
Nathwani D, Lawson W, Dryden M, Stephens J, Corman S, Solem C, Li J, Charbonneau C, Baillon-Plot N, Haider S, Eckmann C. Nathwani D, et al. Among authors: charbonneau c. Clin Microbiol Infect. 2015 Sep;21 Suppl 2:S47-55. doi: 10.1016/j.cmi.2015.03.023. Epub 2015 Jul 18. Clin Microbiol Infect. 2015. PMID: 26198369 Free article. Review.
Weight-based antibiotic dosing in a real-world European study of complicated skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus.
Lawson W, Nathwani D, Eckmann C, Corman S, Stephens J, Solem C, Macahilig C, Li J, Baillon-Plot N, Charbonneau C, Haider S. Lawson W, et al. Among authors: charbonneau c. Clin Microbiol Infect. 2015 Sep;21 Suppl 2:S40-6. doi: 10.1016/j.cmi.2015.05.030. Epub 2015 Jul 20. Clin Microbiol Infect. 2015. PMID: 26206621 Free article.
Antibiotic treatment patterns across Europe in patients with complicated skin and soft-tissue infections due to meticillin-resistant Staphylococcus aureus: a plea for implementation of early switch and early discharge criteria.
Eckmann C, Lawson W, Nathwani D, Solem CT, Stephens JM, Macahilig C, Simoneau D, Hajek P, Charbonneau C, Chambers R, Li JZ, Haider S. Eckmann C, et al. Among authors: charbonneau c. Int J Antimicrob Agents. 2014 Jul;44(1):56-64. doi: 10.1016/j.ijantimicag.2014.04.007. Epub 2014 May 16. Int J Antimicrob Agents. 2014. PMID: 24928311 Free article.
Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections.
Dryden M, Baguneid M, Eckmann C, Corman S, Stephens J, Solem C, Li J, Charbonneau C, Baillon-Plot N, Haider S. Dryden M, et al. Among authors: charbonneau c. Clin Microbiol Infect. 2015 Sep;21 Suppl 2:S27-32. doi: 10.1016/j.cmi.2015.03.024. Epub 2015 Jul 18. Clin Microbiol Infect. 2015. PMID: 26198368 Free article. Review.
Treatment of immunocompromised patients with suspected invasive fungal infections: economic analysis of diagnostic-driven versus empirical strategies in Algeria and Egypt.
Kaci Z, Shalaby L, Kamal S, Boudjerra N, Gao X, Xue M, Ait Belkacem S, Gab Allah Ibrahim A, Kotb R, Charbonneau C. Kaci Z, et al. Among authors: charbonneau c. Expert Rev Pharmacoecon Outcomes Res. 2019 Dec;19(6):693-700. doi: 10.1080/14737167.2019.1604225. Epub 2019 May 6. Expert Rev Pharmacoecon Outcomes Res. 2019. PMID: 31055986
128 results